---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292934235.md"
description: "During Thursday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Liminatus Pharma (up 55.6%), Agape ATP (up 53.57%), and Atai Life Sciences (up 32.92%). Conversely, notable losers were Alpha Compute (down 33.5%), Senti Biosciences (down 25.58%), and VivoSim Labs (down 25.41%). The list highlights substantial price movements across various market capitalizations in the healthcare sector."
datetime: "2026-07-16T17:05:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292934235.md)
  - [en](https://longbridge.com/en/news/292934235.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292934235.md)
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Liminatus Pharma** (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million.
-   **Agape ATP** (NASDAQ:ATPC) shares moved upwards by 53.57% to $3.87. The market value of their outstanding shares is at $2.5 million.
-   **AtaiBeckley** (NASDAQ:ATAI) stock increased by 32.92% to $7.12. The market value of their outstanding shares is at $1.9 billion.
-   **CareDx** (NASDAQ:CDNA) stock increased by 24.6% to $37.07. The company's market cap stands at $1.5 billion.
-   **CEL-SCI** (AMEX:CVM) stock rose 24.18% to $1.43. The market value of their outstanding shares is at $20.0 million.
-   **China Pharma Holding** (AMEX:CPHI) stock moved upwards by 20.45% to $1.32. The company's market cap stands at $44.5 million.

### Losers

-   **Alpha Compute** (NASDAQ:ALP) stock declined by 33.5% to $0.21 during Thursday's regular session. The market value of their outstanding shares is at $7.5 million. The company's, FY earnings came out yesterday.
-   **Senti Biosciences** (NASDAQ:SNTI) shares declined by 25.58% to $0.43. The market value of their outstanding shares is at $18.1 million.
-   **VivoSim Labs** (NASDAQ:VIVS) shares decreased by 25.41% to $0.64. The market value of their outstanding shares is at $2.9 million. The company's, Q4 earnings came out 2 days ago.
-   **Modular Medical** (NASDAQ:MODD) stock fell 16.0% to $3.52. The market value of their outstanding shares is at $22.6 million.
-   **Jaguar Health** (NASDAQ:JAGX) stock fell 15.39% to $1.65. The market value of their outstanding shares is at $9.3 million.
-   **Lakewood-Amedex** (NASDAQ:LABT) shares decreased by 14.82% to $2.07. The market value of their outstanding shares is at $4.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md)
- [LIMN.US](https://longbridge.com/en/quote/LIMN.US.md)
- [SNTI.US](https://longbridge.com/en/quote/SNTI.US.md)
- [ALP.US](https://longbridge.com/en/quote/ALP.US.md)
- [ATAI.US](https://longbridge.com/en/quote/ATAI.US.md)
- [VIVS.US](https://longbridge.com/en/quote/VIVS.US.md)
- [CDNA.US](https://longbridge.com/en/quote/CDNA.US.md)
- [CVM.US](https://longbridge.com/en/quote/CVM.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [MODD.US](https://longbridge.com/en/quote/MODD.US.md)
- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [LABT.US](https://longbridge.com/en/quote/LABT.US.md)
- [LIMNW.US](https://longbridge.com/en/quote/LIMNW.US.md)

## Related News & Research

- [Liminatus Pharma annual meeting draws 48.31% of shares represented](https://longbridge.com/en/news/294876806.md)
- [CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday](https://longbridge.com/en/news/295661964.md)
- [Do Wall Street Analysts Like Nasdaq Stock?](https://longbridge.com/en/news/295411807.md)
- [VivoSim Labs announces annual shareholder meeting](https://longbridge.com/en/news/295411044.md)
- [VivoSim Labs issues 9,896,718 shares on warrant exercises](https://longbridge.com/en/news/295105778.md)